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Mass Culturing Soil Bacteria from Radium Springs and Analysis
of Antibiotic Activity
Abstract
Antibiotics have become a regularity in human life. Discovered accidentally, they
proved to be vital to public health. Since then, they have become integrated into a
variety of widely used products such as detergents, soaps, and clothes. Unfortunately,
the overuse of antibiotics as a precautionary tool for the betterment of public health has
led to an era in which bacterial strains have evolved resistance and antibiotics are
becoming increasingly useless. For example, Enterococcus faecalis, one of six
ESKAPE pathogens prevalent in nosocomial infections, is commonly found in the GI
tract, but frequently causes infections leading to endocarditis, urinary tract infections,
and meningitis. E. faecalis is multi-drug resistant, making it difficult to control once an
infection arises. It’s resistance against vancomycin, however, has drawn the most
attention. Vancomycin is currently the only line of defense against many pathogenic
bacteria, such as Staphylococcus aureus. It is possible for E. faecalis to transfer this
resistance to other pathogens that it comes into contact with, such as S. aureus.
The purpose of this study is to determine whether a new source of antibiotics,
which could defend against E. faecalis, may be identified from pathogens found at a
location that has been sparsely examined. Soil from Radium Springs in Albany, Georgia
has been filtered, cultured, and assessed for antibiotic secretions using a diverse array
of methods. Preliminary results show a modest level of E. faecalis inhibition by
secretions from soil pathogens incubated at 37℃ under both aerobic and anaerobic
conditions using a low-nutrient medium, R2A agar. These methods will aid with culturing
a wide variety of bacteria in an array of different conditions in hopes of identifying a
usable source of antibiotics, capable of competing with aggressive and pathogenic
bacteria such as E. faecalis.
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1. Introduction
1.1 The Fight between Antibiotics and Bacteria’s Continued Resistance
Penicillin was the first antibiotic available to the public, discovered by Dr.
Alexander Fleming. In 1929, Fleming noticed that an agar plate left out culturing
Staphylococcus strains produced zones of inhibition (ZOIs) and the rest is history (32).
Before this period in time, minor infections, if not treated, could become completely
uncontrollable. This was especially the case with the occurrence of World War I and
World War II. Soldiers, isolated on the battlefield, would die from infections caused by
small wounds. However, the introduction of penicillin revolutionized medical care for
soldiers. Soon after seeing the results of antibiotics implemented into the military as well
as in small scale studies, penicillin became available to the public by the early 1940’s.
With the discovery of penicillin came a flood of other antibiotics that proved as
effective against bacterial infection. Between 1935 and 1968, 14 different classes of
antibiotics were introduced to the public, as seen in Figure 1 (35). Many diseases which
were once problematic came close to eradication as more and more antibiotics were
uncovered. For example, before the Age of Antibiotics, approximately 80% of all
bacterial meningitis cases resulted in death (33). Now, that rate is lowered to 10% and if
treated early enough, most patients are able to completely recover (33). It was truly a gift
to mankind, giving humans the ability to heal rapidly from small infections and to even
extend life-expectancy by eight years (34).

Figure 1: Timeline of the Discovery of Classes of Antibiotics. This timeline shows the years in which
each major class of antibiotic was discovered, showing a surge of discoveries from 1935-1968 and a decline
in the following decades. Modified from http://www.rff.org/files/sharepoint/WorkImages/Download/ETC06.pdf (35)
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Figure 2: Events in the Age of Antibiotics. Timeline shows milestones through the Age of Antibiotics,
including the years in which antibiotic resistance became prevalent. Modified from
http://mmbr.asm.org/content/74/3/417/F1.expansion.html

Soon the focus of pharmaceutical companies quickly turned toward massproduction instead of investing in research. There were so many antibiotics available
that the greed of those very pharmaceutical companies seized control and antibiotic
production rapidly increased (32). In 1954, approximately 2 million pounds of antibiotics
were produced each year. These numbers have only increase with every passing
decade (11). Sadly, profits became the top priority. More than 90% of studies made
between 1980 and 2003 showed that pharmaceutical companies would see a decrease
in profits if the budget for antibiotic research was increased (34). Most companies would
only make minor adjustments to their drugs and market them as new, instead of actually
trying to find new ones. After the late 1960’s, the world entered what some have called
an “Antibiotic Discovery Void” or “The Lean Years” as shown in Figure 2 (3). Only 5 new
classes of antibiotics have been uncovered in the last four and a half decades as shown
in Figure 1 (35). However, more than 50 million pounds of antibiotics are produced
annually (17). This overproduction of antibiotics makes them so easily available and has
led to an overuse of antibiotics. Approximately 150 million prescriptions are written to
outpatients each year. Of those prescriptions, it is estimated that 50 million of them are
completely unnecessary as reported by the Center of Disease Control (11). Because of
this, the world was unprepared when the first antibiotic resistance plasmids started to
emerge (3).
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Cycle A

Cycle B

Figure 3: The Cycle of Antibiotic Overuse. These cycles of overuse of antibiotics in crops, livestock, and
healthcare all largely contribute to antibiotic resistance. Modified from http://www.computescotland.com/amrtry-music-song-8155.php

The overuse of antibiotics can be seen in several ways, apart from prescriptions,
shown in Figure 3. One variable is the wide use of antibiotics in crops and livestock. To
aid in crop production and quality of livestock, antibiotics are dispersed into the fertilizer
laid on crops and in the food fed to animals. In addition, the animals also graze on the
grass that surrounds the crops which gives them a double dose of antibiotics. These
crops and animals are then processed and fed to the public, as shown in Cycle A of
Figure 3. Antibiotics have flooded human life in so many ways. Not only is our food
pumped full of antibiotics, but soaps, lotions, cleaning products, and other items that we
come into contact every day also have varying concentrations of antibiotics present (11).
This makes it very difficult to avoid them.
In addition, wide availability of antibiotics has also caused doctors to
overprescribe antibiotics as a precaution whenever patients enter their exam rooms.
Though infection has a high probability of occurrence, as stated before, many times
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prescriptions are unnecessary. Patients often do not take the full dose of antibiotics
prescribed which paves a way for resistant bacteria to flourish, described in Figure 4
(11). Once resistant bacteria develops within one person, that resistant bacteria can be
passed on. Before long, an entire community can be exposed to an antibiotic resistant
bacteria, shown in Cycle B of Figure 3. With all of these contributing sources of
antibiotics, humans have become a walking production factory for resistant bacteria. And
as more bacterial strains are exposed to antibiotics, the rate at which they may be able
to evolve and produce resistance grows tremendously.

Figure 4: How Antibiotic Resistance Happens. Antibiotics will kill a majority of bacteria causing infection.
However, if antibiotics are not administered properly, a few bacteria will survive. These survivors are
resistant to the given antibiotic and will multiply. Before long, only the antibiotic resistant bacteria are
thriving. When this occurs multiple times, multidrug resistant bacteria arise.
Modified from http://www.cdc.gov/getsmart/community/about/antibiotic-resistance-faqs.html

Mutations are a part of the evolutionary cycle, allowing the survival of different
species through the ever-changing climate of our world. Since bacteria have a simple
structure, coupled with their short life cycle, they are able to mutate and evolve more
rapidly. As a result, scientists have not been able to keep up with the rate of antibiotic
resistance in microbes as they evolve. Now there are many strains in existence which
are able to render antibiotics virtually useless through three mechanisms (1, 2, 17):
1. Prevention of antibiotic access to the target bacteria, as shown in Figure 5a with the
antibiotic-efflux pump. Antibiotics are essentially pumped out of the bacterial cell
before it can do any damage.
2. Inactivation of the antibiotic by destruction or modification of the antibiotic, as shown
in Figure 5b with the antibiotic-degrading enzyme. The microbe will release
enzymes that will attach itself to the antibiotic and use hydrolysis, group transfer,
or redox mechanisms to immobilize the antibiotic.
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3. Alteration and elimination of the antibiotic target site, as shown in Figure 5c with the
antibiotic-altering enzyme that essentially alter or replace molecules that are
normally bound by an antibiotic (28).

Figure 5: Mechanisms of Mutation in Bacteria. There are three mechanisms that target bacteria use as
defenses against antibiotics which involve an efflux-pump to eject the antibiotic (a), inactivation through
modification of the antibiotic (b), or altering the target site (c). Modified from
http://www.slideshare.net/Mohammad-Hadi-Farjoo/beta-lactam-other-cell-wall-membraneactive-antibiotics

It is unfortunate that success and scientific breakthrough has caused mankind to
become stagnant, as is evident when examining the rate of antibiotic discovery in
comparison to antibiotic resistance, as shown in Figure 6. With antibiotic resistance, six
strains have risen in prevalence across all patient populations. These strains are
common in a person’s normal flora so the rate of contact is extremely high (24). And as
shown before, since people are exposed to so many antibiotics by just being alive in this
day and age, these strains have gone through resistance cycles multiple times and
therefore, have developed multi-drug resistance. These strains, which have become
known as ESKAPE pathogens, go as follows:
1.
2.
3.
4.
5.
6.

Enterococcus faecalis
Staphylococcus aureus
Klebsiella pneumoniae
Acinetobacter species
Pseudomonas aeruginosa
Enterobacter species
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Figure 6: Timeline of Antibiotic Resistance. The timeline shows the year that an antibiotic is released to
the public (left) versus when resistance to that antibiotic is identified (right). The linking lines connecting the
two events decreases in slope as we get closer to the present, showing that the time period between
introduction and identified resistance has also decreased. Modified from
https://thefern.org/2013/11/imagining-the-post-antibiotics-future/timeline-of-antibiotic-resistance/

ESKAPE pathogens have been grouped by how quickly they gain resistance and
their prevalence in nosocomial infections. Shown in Figure 6, many of these strains have
been coupled with resistance for multiple drugs throughout the years. With this
resistance comes a supporting trend. As time moves forward, with the rate that we are
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exposed to antibiotics from overproduction and overuse, the amount of time between
antibiotic discovery and clinical resistance has shortened. If this trend continues without
efforts to change it, antibiotic resistance will develop almost immediately, as seen in the
case of levofloxacin in Figure 6. This drug, used to treat pneumonia, bronchitis, and
other infections, was developed in 1996. Sadly, since pneumonia and bronchitis are
common ailments, resistance was identified later that year in a strain of Pneumococcus.
Luckily, there are many organizations contributing initiatives working towards a
resolution for the antibiotic resistance problem we face today. The Small World Initiative
is a program which utilizes the work of many scientists and institutions to culture bacteria
found in soil. Still today, soil remains an abundant resource of antibiotics, providing twothirds of the antibiotics in use. The issue is that bacteria found in soil is very difficult to
culture in a lab.

1.2 Enterococcus faecalis
Enterococcus faecalis (E. faecalis) is found in the normal intestinal flora of all
humans, meaning that it is prominent in the landscape of the human alimentary canal.
Humans require Enterococcus species to aid in the digestion of foods among other
processes, making them essential to our living. However, in recent years, E. faecalis has
also been linked to a significant amount of nosocomial infections. Infection is defined as
bacterial strains migrating from their point of origin to an area of the body that it is
normally not found. Since the GI tract runs the length of the human body, it is quite
common for humans to acquire an E. faecalis infection, especially after a procedure in a
hospital (29).
This Gram-positive microbe can be found in a wide array of environments outside
of the human body, including soil, sewage, bodies of water, and food, making it even
more difficult to avoid. E. faecalis has proven to be highly dangerous since it can
withstand harsh environments, growing in the range of 10-45°C and can survive a
temperature of 60°C for 30 minutes (29). In addition, E. faecalis is able to withstand
large fluctuations in pH, oxidative stress, and high levels of salinity, bile acids,
detergents. These characteristics in combination with its growing antibiotic resistance,
particularly vancomycin, makes this bacterial strain extremely dangerous (22). They can
cause urinary tract infections, bacteremia, and endocarditis, which all lead to
complicated nosocomial infections. Minor infection, when treated, can be manageable.
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However, poor use and overuse of antibiotics has strengthened this bacterial strain’s
defense allowing it to mutate and withstand physician’s normal dosage.

1.3 Vancomycin
Vancomycin (Van), a glycopeptide antibiotic that inhibits bacterial cell wall
synthesis, was developed in 1972, shown in Figure 6. Because of its strength, it has
become one of the most common antibiotics used to treat serious infections caused by
Gram-positive pathogens. However, in the 1988, it was discovered that vancomycinresistant Enterococcus isolates were appearing in clinical settings (24). This is
particularly alarming when considering the prevalence of vancomycin in treating illness.
Several different strains of E. faecalis have arisen in the past three decades, all relative
to their level of tolerance towards vancomycin. Tolerance is defined as “the ability of the
organism to survive levels of drugs in well excess of MIC” or the minimum concentration
level of a drug proven to be effective in a microbe’s survival (23). As seen below in Table
1, strains VanA and VanB have a much higher tolerance to vancomycin, requiring a
larger dose to even see any results. As these strains become more and more prevalent
in hospital settings, the chance of other types of multi-drug resistant microbes, such as
Staphylococcus aureus, acquiring this resistance increases. In the case of
Staphylococcus aureus, vancomycin is currently the only reliable antibiotic defense
available in medicine. However, in 2002, a van-resistant strain of Staphylococcus was
already identified. Though this strain is a rarity, once this resistance is transferred,
eradicating this infection will be near impossible.
Table 1: Characteristics of Phenotypes of Glycopeptide-Resistant Enterococci. This table shows the
different strains of E. faecalis and their resistance to vancomycin. Note that VanA and VanB need a higher
dosage of vancomycin for any effects to be observed (23).
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Antibiotic resistance results in greater risks of infection, longer hospital stays,
high healthcare costs, and in some cases death. In the U.S. alone, at least 2 million
people are infected by an antibiotic resistant strain of bacteria every year. Of those,
there are approximately 23,000 cases which directly result in death, as reported by the
Centers for Disease Control in 2014. At the current rate, mankind may reach a point
where resistance is carried over to all of the ESKAPE pathogens, thus eliminating all the
scientific advancement that has been achieved.
However in recent years, large efforts have been made to reverse this
devastating trend. This year alone, the Obama administration has planned to invest $1.2
billion into antibiotic research, as stated in the 2016 budget proposal (4). This is a major
incentive to once again invest time and energy into antibiotic research. Soil is the richest
source of bacteria which produce antibiotic compounds. Though difficult to unearth,
cultivating antibiotic producing microbes in a laboratory setting is quite possible.
However, every gram of soil contains an infinite amount of bacteria that must be sifted
through to find those microscopic gems. This process is both tedious and has been
calculated as unprofitable to many major pharmaceutical companies (34). However,
utilization of the efforts of many institutions can fast track the process, a goal of the
Small World Initiative. As stated in the research guide, “The goal of the Small World
Initiative is to create a global group of undergraduate collaborators, working together to
solve the antibiotic crisis” or at least make strides towards that resolution (2).

1.4 Radium Springs
Radium Springs is an area in Georgia, approximately 3 hours outside of Atlanta,
GA, in Albany GA. The body of water located here maintains a constant temperature of
68 ℃ and has been found to have high levels of radium in the water. Radium is 1,000
more times radioactive than uranium and can be quite dangerous to living things. It
occurs naturally in certain types of earth but is extremely rare. The radium has
penetrated into the soil through absorption of the spring water. This strange quality of the
soil could have induced mutation to the native bacteria, causing them to produce
antibiotics. This unincorporated natural spring has experienced little to no scientific
analysis, making the supply virtually untapped. With the unusual environment
characteristics, it seems that this may be a fruitful resource to look for antibiotic activity.
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1.5 Traditional Methods
Conventionally, bacterial extraction from soil involves multiple steps. Soil is
suspended into a liquid medium, either in distilled water or a culture broth, and allowed
to settle over 24 – 48 hours. From there, the supernatant is extracted and the soil pellet
left behind is discarded. This supernatant is allowed to settle again for approximately 24
hours until a bacterial pellet is acquired. This bacterial pellet, once separated from the
remaining supernatant, is resuspended and diluted for culturing. In previous
experiments, it was found that a serial dilution of 10 was optimal for acquiring workable
colonies with the given growth rates. Without dilutions, colonies become overgrown and
unusable (2). Dilutions are then plated on a general purpose, tryptic soy agar and
allowed to incubate for 24 hours at 37°C. Colonies that form are isolated onto separate
agar plates and selective media is used to identify bacteria that grow, using the
dichotomous key similar to Figures 7 and 8 until a species can be identified. Analysis is
done to observe any antibiotic secretions which could be utilized against antibiotic
resistant strains (2).

Figure 7: Gram Positive Dichotomous Key. Dichotomous key used after Gram staining to identify a Gram
positive unknown bacterial strain. NG: No growth, G: Growth, A/G: Acid and Gas, A: Acid Only. Modified
from http://faculty.lacitycollege.edu/hicksdr/newkeysUnknowns.htm
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Figure 8: Gram Negative Dichotomous Key. Dichotomous key used after Gram staining to identify a Gram
negative unknown bacterial strain. NG: No growth, G: Growth, A/G: Acid and Gas, A: Acid Only. Modified
from http://faculty.lacitycollege.edu/hicksdr/newkeysUnknowns.htm

The methods in use today have become tedious and low yielding in antibiotics
effective against the resistant strains that have developed over time. Scientists have
turned to more efficient measures, condensing all of these steps into just a few for higher
rate of discovery (8). As mentioned before, only a small percentage of antibiotic
resources have been combed through and a quicker process will allow for a wider range
of results. Hopefully, with the combined efforts of the scientific community coupled with
the ever-evolving practices in antibiotic research, new microbes will be uncovered.
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2. Enterococcus faecalis Growth Curve
2.1 Purpose:
In order to observe the effects of the soil bacteria on the growth of E. faecalis, the
bacteria must interact with E. faecalis during the log phase of the bacterial growth, a
period of exponential growth shown in Figure 9 (26). To pinpoint the time frame in which
E. faecalis has reached this stage during different parameters, a growth curve must be
established for all given growth conditions.
Optical density readings (OD readings) will be used to chart growth. This method
utilizes light by scattering it through a suspension of microorganisms to measure the
density of the sample. This reading is an indication of the biomass present in the
suspension which can be used to determine the rate of growth. Sudden increases in
readings indicate a period of optimal growth while repeated readings of the same value
means that the bacteria have entered the stationary phase (27). A period of 72 hours
was chosen to ensure a growth plateau is reached.

Figure 9: Bacterial Growth Curve Model. Sample graph shows the growth trend of bacteria. The log
phase, indicated by the blue box, represents the desired phase of bacteria growth for isolation and testing.
Modified from http://accounts.smccd.edu/case/biol230/growth/

2.2 Hypothesis:
According to literature, the time frame for E. faecalis to reach log phase at 37℃
should be approximately 8 hours. This time period will increase at the set temperature
decreases as well as decrease as temperature increases.
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2.3 Materials and Methods:
2.3.1 Trials 1-3
E. faecalis ATCC 29212 was used as the tester strain and rehydrated according
to the attached product sheet, see appendix 1a and 1b. After rehydration, a glycerol
stock was made using 50% glycerol and 50% Tryptic Soy Broth (TSB). A sample was
taken using a sterilized inoculating loop placed in 20 mL of TSB to make a working
stock. The glycerol stock was placed in a -80 ℃ storage unit for future use. This sample
was incubated for 8 hours and examined for turbidity. After the incubation period, an

inoculating loop was sterilized and used to take a sample. This sample was streaked on
tryptic soy agar (TSA) plates and incubated for 24 hours to check colony morphology.
This process is repeated every 3 weeks to keep a fresh working stock available.
For the growth curve at each temperature setting, six conical tubes (15 mL) were
filled with 10 mL of TSB each and inoculated with a 1 µL sample of E. faecalis working
stock. Conical tubes containing the tester strain were incubated over a period of 72
hours, see appendix 2a for details. For each bacteria strain, there will be two sets of
three 15 mL conical tubes, one conical tube for each 12-hour period. This totals 6
conical tubes which will span over the full 72 hour period. One set is incubated 12 hours
before the other to cover the full time period, schedule for incubation and readings
shown in Figure 10.
Initial OD readings were taken using aliquots of 1 mL in a cuvette placed in a
Beckman Coulter DU 730 Life Science UV/Vis Spectrophotometer. OD readings were
read at a range between 450 nm - 650 nm to capture the 600 nm reading, the
recommended value for E. faecalis, as well as values above and below this value (25).
Each conical tube contained enough volume for readings, plus an excess for error,
during a 12 hour period, 6 tubes in total for the entire 72 hour period at one temperature.
Twelve conical tubes were prepared for two temperature settings, one set of 6 tubes for
a growth curve at 25 ℃ and one set of 6 tubes for 37℃. After the 72 hour cycle, all

readings for E. faecalis were compiled into an Excel spreadsheet along with readings for
a control, consisting only of TSB. To normalize the values, the E. faecalis values were
adjusted using the following formula:
Normalized values = E. faecalis OD readings - Control OD readings
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Ex: E. faecalis
Six conical tubes- Two sets of 3

Figure 10: Spectrophotometer Schedule for Tester Strain Growth Curve. This schedule describes the
time interval after initial incubation that OD readings were taken and to which hour mark those readings
correspond. Two sets were used, set 1 indicated in red and set 2 indicated in blue, to achieve a full 72-hour
growth curve.

2.3.2 Trial 4
The glycerol stock was revisited to make a fresh working stock since the original
working stock is at risk for contamination. The Synergy HT microplate reader was found
to be able to incubate and shake while taking absorbance readings in regulated
intervals. The Gen5, version 2.00.18, BioTek (Winooski, VT, USA) software was used to
capture this data. Growth curves for E. faecalis were done simultaneously with lab
partner, Vash Patel’s tester strains to fully utilize equipment, see appendix 2b.
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A 6-well plate was used to calculate the growth of controls and tester strains.
Placement and volumes for each well are displayed as depicted in Figure 11. Volumes
were determined by taking a ratio of the volumes from the manufacturer protocol.

Figure 11: 6-Well Plate Configuration. The 6-well plate used in the Synergy HT microplate reader was
configured to hold two controls (blue) and three tester strains (yellow). The volumes, shown above, are 1/10
of the volume used in the previous trials. The term “AN Control” represents the A1 well.

To set up the reader, a new protocol was established according to the desired
growth conditions. Gen5 software was set up in the following fashion (the growth curve
at 37℃ is used as a sample).
→ Set temperature: 37℃
→ Start read (24:00:00) Interval (01:00:00)
→ Read (600, 650)
→ Shake (orbital, continuous)
→ End read
The protocol is set to maintain a consistent temperature until the plate is ejected
from the reader. The read is set to span over a 24 hour period for the given temperature
setting to ensure that a plateau is reached. Absorbance readings are set to read at both
600 nm and 650 nm every hour. As stated before, the ideal OD reading for E. faecalis is
600 nm, which is also true for S. aureus. The OD reading 650 nm was set for
Acinetobacter baumannii. The plate tray is also set to continuously shake in an orbital
fashion consistently through the 24 hour period. A clear plastic adhesive sheet was
placed on top of the plate to seal the bacterial sample to prevent contamination.
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The plate reader was checked every 6 hours to observe changes and make sure
the protocol was running correctly. Once the full 24 hour interval, the plate was ejected
from the reader and discarded. For the growth curve at 25℃, the protocol was adjusted
to a 36 hour period and a 48 hour period for 18℃. Values were normalized.

2.4 Results:
2.4.1 Trial 1-3
This process was repeated 3 times until a full 72 hour incubation period was
reached, values shown in Table 2 and 3. The first and second attempts were aborted
due to contamination in the control samples and non-uniform growth in all tubes. After
the third attempt, all data was compiled together and normalized, shown in Table 4 and
a growth curve was charted from the normalized values (shown below in Figure 12) for
both 25℃ and 37℃. The curves were irregular and the protocol was adjusted to
successfully complete a growth curve.
Table 2: E. faecalis OD Readings at 25℃ (Spectrophotometer). OD values acquired with the Beckman
Coulter DU 730 Life Science UV/Vis Spectrophotometer at 3-hour intervals at 25℃. The highlighted
wavelength indicates the optimal wavelength for this tester strain.
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Table 3: E. faecalis OD Readings at 37℃ (Spectrophotometer). OD values acquired with the Beckman
Coulter DU 730 Life Science UV/Vis Spectrophotometer at 3-hour intervals at 37℃. The highlighted
wavelength indicates the optimal wavelength for this tester strain.

Table 4: Normalized OD Readings for EF at 25℃ and 37℃ (Spectrophotometer). These values were
calculated by subtracting the OD readings of the Control TSB from the OD readings of the tester strain from
the spectrophotometer.

29

Figure 12: E. faecalis Growth Curves (Spectrophotometer). Growth curves for E. faecalis graphed using
the normalized data obtained from Beckman Coulter DU 730 Life Science UV/Vis Spectrophotometer in
Table 4.

2.4.2 Trial 4
To complete Objective 1, all soil bacteria will be incubated on a lawn of E.
faecalis at 18℃, 25℃, and 37℃. Therefore, growth curves for all temperature settings
were made, see Tables 5-9. In addition, there are two different kinds of incubators
available for use in the lab, one with shaking capabilities and one without. Due to this,
growth curve protocols were also made with use of a shaker and without. This method
proved to be most successful, minimizing contamination since the plate was sealed prior
to being placed in the plate reader and keeping growth conditions constant.
As stated before, all OD values were normalized, subtracting the readings for the
control TSB values, and leaving the absorbance values of the bacterial samples. A
corresponding graph was made with this data, see Figure 13. Using this method
provided the best results for the growth curve. All the OD readings were compiled
together into one Excel spreadsheet to acquire growth curves at all temperature settings,
shaking and not shaking, shown in Figure 13.
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Table 5: E. faecalis OD Readings at 18℃, shaking (Synergy HT Microplate Reader). Data obtained
using a Synergy HT microplate reader with Gen5 version 2.00.18 software. E. faecalis OD readings read at
600 nm at 18℃ with continuous orbital shaking over a period of 48 hours to observe full log phase.
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Table 6: E. faecalis OD Readings at 25℃, no shaking (Synergy HT Microplate Reader). Data obtained
using a Synergy HT microplate reader with Gen5 version 2.00.18 software. E. faecalis OD readings read at
600 nm at 25℃ over a period of 36 hours to observe full log phase.

Table 7: E. faecalis OD Readings at 25℃, shaking (Synergy HT Microplate Reader). Data obtained
using a Synergy HT microplate reader with Gen5 version 2.00.18 software. E. faecalis OD readings read at
600 nm at 25℃ with continuous orbital shaking over a period of 36 hours to observe full log phase.

32
Table 8: E. faecalis OD Readings at 18℃, shaking (Synergy HT Microplate Reader). Data obtained
using a Synergy HT microplate reader with Gen5 version 2.00.18 software. E. faecalis OD readings read at
600 nm at 37℃ over a period of 24 hours to observe full log phase.

Table 9: E. faecalis OD Readings at 18℃, shaking (Synergy HT Microplate Reader). Data obtained
using a Synergy HT microplate reader with Gen5 version 2.00.18 software. E. faecalis OD readings read at
600 nm at 37℃ with continuous orbital shaking over a period of 16 hours to observe full log phase.
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Figure 13: E. faecalis Growth Curves (Synergy HT Microplate Reader). Graph shows growth curves for
E. faecalis acquired through an incubating plate reader (Synergy HT microplate reader) with Gen5 version
2.00.18 software. Curves were measured for 18℃, 25℃, and 37℃. The plate reader was capable of reading
at a designated time interval, at a designated OD measurement, at temperatures between 15℃ - 50℃, and
with shaking settings. This allowed the entire process to be automated.

2.5 Discussion:
2.5.1 Trials 1-3
Though a full 72-hour period was reached using this method, the gathered data
did not result in a normal growth curve for bacteria. A log phase with corresponding
plateau cannot be identified with the acquired data. It was identified that the pipettors
had a black unidentified substance inside which may have contaminated the samples. In
addition, constantly taking the samples in and out of the incubator to take readings
increases the occurrence of contamination. Contamination at any point will introduce
new bacteria to the sample and cloud the results which would account for the multiple
peaks in the growth curves. New bacteria could also contribute their own defenses that
kill the tester strain which explains the multiple dips in the growth curve. With this issue,
a new method was developed to combat the contamination.
2.5.2 Trial 4
This method of using a plate reader set to take hourly OD readings while incubating and
shaking was incredibly successful and minimized contamination. In addition, this did not
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require a person to physically sit down and manually measure the optical density of the
sample which allowed a stable and controlled environment for the bacteria to grow in.
Also, all of the growth curves acquired through this method had a visible log phase and
plateau. The data will be used as a timeframe to work around when incubating soil
bacteria samples with the tester strain. It will also be useful in creating the working stock,
incubating all samples to mid log phase for optimal cultures, shown in Table 10.

Table 10: E. faecalis Growth Curve Log Phase. After analysis of the growth curves and data from Trial 4,
this table was made for culturing future working stock. This shows the hours after incubation which strain E.
faecalis ATCC 29212 enters into log phase, what OD reading the strain measures at for this time, when the
strain plateaus, and at what OD reading the plateau occurs at. This information was used to make the
working stock and incubate it to mid log phase according to the temperature setting. This data was also
used to mark a time frame which to incubate the soil bacteria samples with the tester strain.
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3. Objective 1: Obtaining and Filtering Bacteria
3.1 Purpose:
To sort through all the strains as well as eliminate waste and debris, the bacteria
needs to be filtered out and separated from soil particles for adequate culturing (14). For
ease of bacterial transfer, bacteria will be collected on filter papers once separated.

3.2 Hypothesis:
Using filter papers, bacteria from the soil sample obtained from Radium Springs,
GA will be separated from the soil particles and waster. Filter paper sizes .65 µm, .45
µm, and .22 µm will be most useful since these encompass the average sizes of bacteria
found in soil (6, 14).

3.3 Materials and Methods:
3.3.1 Obtaining and Drying Soil Samples
Soil from Radium Springs was obtained using a soil probe and plastic trowels,
see appendix 3. At the site, two locations were scouted out, one closer to the water
source and one closer to the perimeter of the area. The soil probe was plunged into the
soil, approximately a foot deep. Contains of the probes were placed in sterile plastic
sample bags and labelled with the appropriate coordinates. Two bags were filled from
each location. Notes of the day's temperature and climate were noted along with the
coordinates (Table 11)

Table 11: Radium Springs Soil Sample Conditions. Data collected about Radium Springs, Georgia using
Accu Weather on the day of soil collection (October 12, 2015). Data collected and modified from
http://www.accuweather.com/en/us/albany-ga/31701/octoberweather/328216?monyr=10/1/2015&view=table

Jurassic Park 1 (J1)
Jurassic Park 2 (J2)
Zoolander 1 (Z1)
Zoolander 2 (Z2)

Coordinates

Location Description

31/525, -84.135
31.525, -84.135
31.524, -84.136
31.524, -84.136

Closer to water source
Closer to water source
Perimeter of area
Perimeter of area

Temperature Precipitation
18°C
18°C
18°C
18°C

0.0 in
0.0 in
0.0 in
0.0 in

Once the soil was brought back to the lab, the soil samples were prepared for
long term storage and testing, see appendix 4. Each bag was emptied onto paper towels
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and placed into a sterile hood. Each sample was properly labelled to ensure there is no
confusion after drying. The blower was turned on and the samples left under the hood to
dry for 24 hours at room temperature. After the allotted time, the soil samples were
checked for moisture and re-bagged in new sterile sample bags. After a day, noticeable
condensation appeared in samples Jurassic Park 2 and Zoolander 2. The drying
procedure was repeated for another 24 hours to ensure the soil was completely dry. All
soil samples were stored at 4℃.

3.3.2 Filtering Bacteria
A filtration device was constructed to effectively filter and separate the bacteria
from the soil particles and waste (9). The soil particles serve as a good host environment
for the bacteria but must be removed for experimental purposes (15). Figure 14 depicts
the setup of the filtration device. The Vacuubrand Vacuum Pump Unit PC101 NT series
and the Fisherbrand™ Porcelain Buchner Funnel with Fixed Perforated Plates (FB966B)
were used in this experiment.

A.

B.

Figure 14: Objective One Filtration Device. A vacuum is connected to a vacuum flask using a plastic
hose. Through the top of the flask, a Buchner funnel is attached using a rubber stopper with a hole carved
through the middle. Filters are placed inside the Buchner funnel to filter bacteria. Once the entire device is
assembled, samples are poured into the funnel and filtrate is collected in the flask. A Bunsen burner is used
to keep the area sterile. See both a visual representation (A) and the laboratory setup (B).

To make the soil sample solution that would be filtered through the filtration
device, every gram of soil would be added to 10 mL of dI water. Therefore, 4 grams of
soil would be dispersed in 40 mL of dI water. It is estimated that since each filter needs
to contain enough bacteria to stamp multiple plates, at least 10 mL of solution would be
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needed to carry out the objective. In addition, an aliquot of solution must be saved for
future use so an extra 2 grams of soil was dispersed in 20 mL of dI water.. So if 6 filters
are needed, 8 grams of soil needs to be dispersed in 80 mL of dI water. One filter would
only be used to stamp four agar plates maximum. This system was used for the all
experiments. Tests and all experiments were done using soil sample Zoolander 1. Soil
was measured out and placed in a beaker with dI water. A stir bar was added and the
beaker was placed on top of a magnetic stirrer with a hot plate. Solution was mixed for
approximately 10 minutes for full dispersion (5). The aliquot meant for storage was
measured out, placed in a conical tube, labelled, and stored at 4℃. Once the soil and
debris were filtered out, the debris was placed in a 15 mL conical tube and stored at 4℃
in case it is needed in the future.
Sartorius™ Quantitative Grade 389 100 mm Filter Papers (FT3102100) with the
pore size 8-12 µm were used initially to filter out soil, waste, and debris. Multiple filters
were used initially to separate the soil since there was frequent clogging (7). These
filters were discarded after use. Filters with pore size .65 µm, .45 µm, and .22 µm were
used to both filter the bacteria as well as categorize the bacteria according to size (14).
The filters were unwrapped, placed into the Buchner funnel, and removed after each
use. With each filter, the entire solution is emptied into the Buchner funnel, filtered,
gathered in the flask, and removed to be filtered again by the next lowest filter pore size.
The solution is essentially filtered 4 times per experiment, once to separate debris and
three times to catch bacteria on the three filters of varying size. After use, the filters were
placed in the original plastic packaging, labelled, and stored at 4℃. The leftover filtrate
was placed in a 50 mL conical and stored at 4℃ in case it is needed in the future.

3.4 Results:
3.4.1 Obtaining and Drying Soil Samples
The soil was dried thoroughly using the proposed method and is ready to use for
experiments and culturing.

3.4.2 Filtering Bacteria
Using the filtration device was successful in obtaining the microbes present in the
soil while also separating out debris and other unwanted particles. All filters with trapped

38
bacteria were immediately used to culture and complete Objective Two. Filters were
saved and stored at 4℃ in case they are needed for further examination in the future.

3.5 Discussion:
3.5.1 Obtaining and Drying Soil Samples
It was important to document all the information for the specific day that the soil
was collected for experimental design. Certain bacteria thrive under certain conditions
and knowing the area’s climate and environment will help when preparing for culturing
(15). In addition, it is necessary to dry out the samples to preserve the integrity of the
sample. If moisture is locked into the bag with the sample, mold or fungus could develop
in the bag and cloud the results.

3.5.2 Filtering Bacteria
If a valuable bacterial strain is identified after culturing, soil particles could
interfere with any identification or analysis so it’s important to filter them out (15).
Filtering out the bacteria from the soil using filter papers seemed to be the least
expensive and least invasive method (7). Certain problems cannot be avoided such as
initial clogging in the filters from oversized particles. However, using multiple 8 - 12 µm
filters, one per 10-15 mL of solution, helps filter out the solution without adding too much
pressure to the solution or the bacteria.
After filtering out soil particles and debris, the specialized filters were placed in
the funnel for bacterial separation. These filter papers were chosen for their pore size,
sterile quality, paper diameter, and grid printed on one side. A few problems arose with
this choice, mainly with the diameter of each filter. When placed into the Buchner funnel,
the paper is the same diameter as the funnel. Initially, the filters were purchased
because of the exact fit, however when filtering, some filtrate could easily slip between
the edge of the filter paper and the wall of the funnel. Though the papers are stamped
onto agar for Objective 2, this slight slippage would cause some error in bacterial
categorization and culturing. In addition to the diameter, the filters are extremely fragile
and hard to handle. If not placed into the Buchner funnel properly, the filters will rip with
any small amount of tension. This fragility could also contribute to some error in
categorization and culturing while handling and transferring the bacteria onto agar.
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4. Objective 2: Culturing Bacteria
4.1 Purpose:
Culturing bacteria in a lab has limiting factors and culturing the standard way
does not take full advantage of the available microbes that is found in soil (2). Using
different temperature settings, different agars, and different growth conditions will allow
for more diversity in bacteria. The more variation in bacterial strains, the higher the
probability to find a valuable antibiotic resource against an ESKAPE pathogen.

4.2 Hypothesis:
After stamping the previously acquired bacteria from filter papers onto an E.
faecalis lawn on agar, ZOIs will be observed around bacterial colonies. These bacterial
will be producing an antibiotic usable against the tester strain.

4.3 Materials and Methods:
After filtration, each filter paper was inverted and stamped onto an agar plate with
an E. faecalis lawn, see appendix 5. There was a corresponding plate for each pore
size, each agar type, and each temperature setting. This resulted in 36 separate plates
for the proposed growth conditions, shown in Figure 15. Initial trials (Trials 1-3) were
carried out only using TSA at 37℃ to find the most effective method to culture bacteria.
Protocols were modified until ZOIs were observed in Trial 4, see appendix 6.

Figure 15: Objective Two Stamping Filter Papers. Diagram depicts sample plates for each pore size.
Each pore size will have 12 corresponding plates using two different agars (TSA and R2A) and three
different temperature settings (18℃, 25℃, and 37℃). Three different pore sizes resulted in 36 plates.
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4.3.1 Trial A
From the working stock, 50 µL of E. faecalis was pipetted onto 50 mm plates
containing 5 mL of Tryptic Soy Agar (TSA) each. Roll & Grow Plating Beads MP
Biomedicals (15000550) were used to distribute the tester strain evenly over the surface
of the agar. Approximately 3-5 beads were placed into each plate and rocked back and
forth for complete coverage. After beading, the previously acquired filter papers were
inverted and stamped onto the agar plates. Tweezers were used to place the filter on top
of the agar and a glass stir rod used to press the filter down. All supplies were flame
sterilized before and after each use. A total of 8 plates were prepared to be incubated at
37℃ for an initial test, shown in Figure 16. Plates were parafilmed after preparation.
The anaerobic plates were prepared before incubation using Mitsubishi™
AnaeroPack 2.5L Rectangular Jars (R685025). Plates are placed inside the jar and a
Mitsubishi™ AnaeroPack-Anaero Anaerobic Gas Generator (R68100) is placed inside to
absorb all oxygen and produce carbon dioxide. A Mitsubishi™ RT Anaero-Indicator
(R684002) is placed inside the container to indicate the presence of oxygen, turning
purple in the presence of oxygen. After preparation, all plates were incubated for 12
hours. After examination, plates with parafilmed, packaged in plastic, and placed in 4℃
for storage.

Figure 16: Control Plate for Filter Paper Temperature Sets. Two controls were used, one for each growth
condition. These controls had a lawn of E. faecalis and no filter stamp. There was a corresponding plate to
each filter for each filter pore size and growth condition, resulting in 8 plates. The abbreviation “AE” dictates
aerobic growth and “AN” for anaerobic growth.

4.3.2 Trial B
Eight plates with an E. faecalis lawn were prepared as previously described in
Trial A and placed in an incubator at 37℃ for 3 hours. After incubation, the previously
acquired filter papers from filtration (Objective 1) were inverted and stamped onto six
TSA agar plates using tweezers. Plates were then incubated a second time for an

41
additional 8 hours. After examination, plates with parafilmed, packaged in plastic, and
placed in 4℃ for storage.

4.3.3 Trial C
With this revised protocol, the chopped agar method was referenced to incubate
the soil bacteria with the tester strain. Four plates were prepared with an E. faecalis lawn
were prepared as described in Trial A. For each plate made with a tester strain lawn, a
corresponding plate was prepared without the E. faecalis lawn, shown in Figure 17.

Figure 17: Chopped Agar Co-Culturing. Stamped agar was chopped up and a piece was placed onto the
TSA E. faecalis lawn. This method was used to solve problems seen in previous trials. The plates made
from this method were incubated at 37℃ aerobically for 12 hours.

The filter papers acquired after completing Objective 1 were then inverted onto
the corresponding plates lacking the tester strain lawn. Both sets of plates (the set with
the E. faecalis lawn and the corresponding set) were placed in the incubator at 37℃ for 4
hours. After the incubation period, all plates were removed from the incubator.
The soil bacteria agar plates (without E. faecalis) were examined and an area of
growth was marked for each. That area was cut out and the surface of the agar with soil
bacteria was inverted onto the E. faecalis lawn, allowing direct contact. Plates were
placed back into the incubator for an additional 8 hours at 37℃. Once removed and
examined for ZOIs, plates were placed in storage at 4℃.
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4.3.4 Trial D
This trial was carried out for temperature settings 37℃ and 25℃ using both TSA
and Low Nutrient R2A agar (R2A). From the working stock, 50 µL of E. faecalis was
pipetted onto 60 mm plates containing 5 mL of TSA or R2A and a lawn was made. The
plates containing the E. faecalis lawn were placed in an incubator at 37℃ for 1 hour,
then stamped using the filter papers, obtained as described in Figure 18.

Figure 18: Aliquots Filtered and Collected Part I. Trial 4 was carried out for temperature sets 25℃ and
37℃ in TSA and R2A. Different filters will be used to keep from contamination. Filters were then inverted
onto the designated agars for incubation.

Anaerobic designated plates were placed in Mitsubishi™ AnaeroPack 2.5 L
Rectangular Jars with gas generators as previously described in Trial 1. Sixteen plates
were made in this trial, eight for each temperature set. Each set had 6 plates for each
filter size and two controls. Plates at 37℃ were incubated for 12 hours and for 24 hours
at 25℃. After incubation periods, plates were removed and stored at 4℃.
4.3.5 Trial E - G
These four trials repeated the protocol used for Trial 4, see appendix 7. The
tester strain lawn was made using the same method as previously described. Each
temperature set requires its own set of six filters obtained using methods from Objective
1, shown in Figure 19.
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Figure 19: Aliquots Filtered and Collected Part II. This figure depicts how filtrate was allotted for the given
growing conditions for one trial, taking into account even distribution of the entire sample through each filter
and how much filtrate is required for each filter for adequate samples. Each filter was stamped twice for both
aerobic and anaerobic growth of the proposed conditions. This method was repeated for Trials E-G.

4.4 Results:
4.4.1 Trial A
Results (Figure 20 and 21) show little growth and no ZOIs.

Figure 20: Trial A Plates Aerobic (Immediately Stamping). E. faecalis lawn made on the surface of TSA
with Roll & Grow Plating Beads (MP Biomedicals). Bacteria filtered using filtration device and immediately
stamped onto the lawn. These plates were incubated aerobically at 37℃ for approximately 12 hours.
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Figure 21: Trial A Plates Anaerobic (Immediately Stamping). E. faecalis lawn made on the surface of
TSA with Roll & Grow Plating Beads (MP Biomedicals). Bacteria filtered using filtration device and
immediately stamped onto the lawn. These plates were incubated anaerobically at 37℃ for approximately 12
hours.

4.4.2 Trial B
Results (Figure 22 and 23) show overgrowth of the soil bacteria and E. faecalis
and no ZOIs are observed.

Figure 22: Trial B Plates Aerobic (3-Hour Stamping Delay). E. faecalis lawn made on the surface of TSA
with Roll & Grow Plating Beads (MP Biomedicals) and initially incubated for 3 hours. Bacteria filtered using
filtration device and stamped onto the lawn afterwards. These plates were incubated aerobically at 37℃ for
approximately an additional 8 hours.

Figure 23: Trial B Plates Anaerobic (3-Hour Stamping Delay). E. faecalis lawn made on the surface of
TSA with Roll & Grow Plating Beads (MP Biomedicals) and initially incubated for 3 hours. Bacteria filtered
using filtration device and stamped onto the lawn afterwards. These plates were incubated anaerobically at
37℃ for approximately an additional 8 hours.
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4.4.3 Trial C
The plates with the stamped samples of soil bacteria (Figure 24) grew at a fast
rate indicating that there are a lot of viable bacterial strains present in the soil samples.
Sections were chosen for their distinct yet isolated colonies.
When examining the plates made adding chopped agar to the tester strain
(Figure 25), it looks as though there are no ZOIs. Overgrown bacteria surround the
inverted pieces of agar. The clearly visible lawn of E. faecalis is unaltered.

Figure 24: Trial C Stamped Plates. Filters obtained after completing Objective 1 were stamped onto blank
TSA plates and incubated at 37℃ aerobically for 4 hours. Once this incubation period passed, plates were
removed and a section was marked containing isolated colonies. These sections were removed, sections
are marked with a red arrow.

Figure 25: Trial C Plates (Chopped Agar). The removed soil bacteria agar from Figure 24 was placed in
the center of the E. faecalis lawn after an incubation period at 37℃ aerobically for 4 hours.

4.4.4 Trial D: Trial 1 of and 25℃ and 37℃
Plates for this trial (Figures 26-31) show some ZOIs in certain growth conditions.
This protocol has been the most successful in culturing the soil bacteria with the tester
strain to see some inhibition. Levels of inhibition vary.
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Figure 26: Trial D TSA Plates 25℃ Aerobic (1-Hour Stamping Delay). TSA stamped with an E. faecalis
lawn and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
aerobically at 25℃ for 24 hour (Trial 1, T1).

Figure 27: Trial D TSA Plates 25℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 25℃ for 24 hours (Trial 1, T1).

Figure 28: Trial D TSA Plates 37℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 1, T1)
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Figure 29: Trial D TSA Plates 37℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 1, T1).

Figure 30: Trial D R2A Plates 37℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 1, T1).

Figure 31: Trial D R2A Plates 37℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 1, T1).
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4.4.5 Trials E - G
Plates for this trial (Figures 32-59) show some ZOIs in certain growth conditions.
Levels of inhibition vary, depicted in Table 12. These results are similar to those found in
Trial D and confirm that the results in Trial D are significant and can be replicated.
Trial E: 18℃ (Trial 1)

Figure 32: Trial E TSA Plates 18℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 1, T1).

Figure 33: Trial E TSA Plates 18℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 1, T1).

Figure 34: Trial E R2A Plates 18℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 1, T1).
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Figure 35: Trial E R2A Plates 18℃ Anaerobic (1-Hour Stamping Delay).R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 1, T1).

Trial F: 18℃, 25℃, and 37℃ (Trial 2)

Figure 36: Trial F TSA Plates 18℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 2, T2).

Figure 37: Trial F TSA Plates 18℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 2, T2).
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Figure 38: Trial F R2A Plates 18℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 2, T2).

Figure 39: Trial F R2A Plates 18℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 2, T2).

Figure 40: Trial F TSA Plates 25℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 25℃ for 24 hours (Trial 2, T2).
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Figure 41: Trial F TSA Plates 25℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 25℃ for 24 hours (Trial 2, T2).

Figure 42: Trial F R2A Plates 25℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 25℃ for 24 hours (Trial 2, T2).

Figure 43: Trial F R2A Plates 25℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 25℃ for 24 hours (Trial 2, T2).
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Figure 44: Trial F TSA Plates 37℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 2, T2).

Figure 45: Trial F TSA Plates 37℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 2, T2).

Figure 46: Trial F R2A Plates 37℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 2, T2).
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Figure 47: Trial F R2A Plates 37℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 2, T2).

Trial G: 18℃, 25℃, and 37℃ (Trial 3)

Figure 48: Trial G TSA Plates 18℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 3, T3).

Figure 49: Trial G TSA Plates 18℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 3, T3).
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Figure 50: Trial G R2A Plates 18℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 18℃ for 48 hours (Trial 3, T3).

Figure 51: Trial G R2A Plates 18℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 18℃ for 48 hours (Trial 3, T3).

Figure 52: Trial G TSA Plates 25℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 25℃ for 24 hours (Trial 3, T3).
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Figure 53: Trial G TSA Plates 25℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 25℃ for 24 hours (Trial 3, T3).

Figure 54: Trial G R2A Plates 25℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 25℃ for 24 hours (Trial 3, T3).

Figure 55: Trial G R2A Plates 25℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 25℃ for 24 hours (Trial 3, T3).
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Figure 56: Trial G TSA Plates 37℃ Aerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 3, T3).

Figure 57: Trial G TSA Plates 37℃ Anaerobic (1-Hour Stamping Delay). TSA with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 3, T3).

Figure 58: Trial G R2A Plates 37℃ Aerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn and
stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated aerobically
at 37℃ for 12 hours (Trial 3, T3).
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Figure 59: Trial G R2A Plates 37℃ Anaerobic (1-Hour Stamping Delay). R2A with an E. faecalis lawn
and stamped with soil bacteria. From left to right, .22 µm, .45 µm, and .65 µm. Plates were incubated
anaerobically at 37℃ for 12 hours (Trial 3, T3).

While looking at all these plates, it was observed that there were certain plates
that had a stronger boundary between the tester strain lawn and the inhibitory zone.
Levels of inhibition are noted in Table 12.

Table 12: Observed Zones of Inhibition for Zoolander 1. This table sums up Trials 1-3 of all temperature
settings 18℃, 25℃, and 37℃ using both aerobic and anaerobic growth conditions with both TSA and R2A.
The strongest inhibitory zones with clear borders were noted with (++), moderate inhibition with a gradual
zone was noted with a (+), and no inhibitory zones were marked with a (--). Plates that showed inhibition in
all three trials are colored in pink and plates that showed inhibition in two trials are colored green. Inhibition
in either one trial or none is marked white.
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4.5 Discussion:
4.5.1 Trial A
When looking at these plates, the cloudy surface of the agar shows little antibiotic
activity. Since the soil bacteria was introduced immediately after the E. faecalis lawn was
made, E. faecalis these results may have occurred since E. faecalis had not entered log
phase. At 37℃, E. faecalis enters the log phase at approximately 4 hours after
incubation. Incubating the plates prior to stamping the filters would change this time
frame. During log phase, bacteria cells are actively metabolizing as they replicate,
making them vulnerable. This is the most important stage to introduce antibiotics. To see
better results, the protocol should be adjusted so that any antibiotic secretions would
come into contact with the tester strain within this vulnerable stage.
4.5.2 Trial B
Looking at these plates, there is a lot of overgrowth. Incubating the plates for the
initial 3 hours was too long, causing the soil bacteria to miss the window of opportunity.
In addition, since the soil bacteria is stamped on top of the tester strain, it may not
receive as much nutrients from the agar. Protocols should be modified to push both the
tester strain and the soil bacteria into log phase for interaction.
4.5.3 Trial C
The rationale of chopping up the agar came from the previous trial in which the
tester strain was overpowering the soil bacteria. In Trial 2, E. faecalis was incubated to
log phase prior to being stamped by the soil bacteria. The modification to incubate
separately and chop the agar would force both the tester strain and the soil bacteria into
log phase. However, “sandwiching” the bacteria between TSA infused both samples with
a lot of nutrients. This lead to the overgrowth observed.
Moving on from this trial, modifications to the protocol will be made to allow the
soil bacteria and the tester strain to interact during log phase. Incubation periods will be
adjusted according to the determined growth curves for each temperature.
4.5.4 Trial D
This protocol seemed to be most successful from all the trials, taking into account
all previous results and issues. Incubating the tester strain seemed to kick start its
growth cycle but not push the tester strain into log phase. Also, since there is so much
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bacteria present in the soil, the growth phase for it should be shorter. Future trials will be
repeated from this protocol, which allowed for the appropriate time of interaction.
Looking at the resulting plates, using TSA at room temperature and R2A at body
temperature resulted in ZOIs. This shows that the bacteria present in the soil found in
Radium Springs, GA are slow growing, confirming the rationale to integrate a variety of
different growth factors. Moving forward, trials will integrate both agars with both aerobic
and anaerobic growth conditions for the three temperature settings for similar results.
4.5.5 Trials E-G
After all three trials and charting the ZOIs, two sets of growth conditions stood
out as having the most potential for antibiotic production. According to Table 12, growing
the bacteria found in the soil at either 18℃ or 25℃ anaerobically on TSA is most fruitful,
contrary to traditional methods. These results show that there could be a significant
antibiotic producing bacteria present in the soil of Radium Springs, GA and culturing
under non-traditional methods helps to uncover them.
Soil is found in many different circumstances and environments, especially soil
found near a water source such as the soil at Radium Springs, GA. Research has found
that soil near water sources receive a very low level of nutrients, which is a valid reason
to use Low-nutrient R2A. In addition, the average annual temperature for Radium
Springs, GA is found to be 18℃. Culturing at a lower temperature similar to the original
source of the soil would allow a great variety of bacteria to thrive. This would lead to a
greater chance in finding an antibiotic producing microbe. Lastly, soil sources vary in
depth, most covering a large distance for root systems. Only the very top of the soil will
be exposed to air. Culturing bacteria in an aerobic environment limits the variability,
especially since the soil sample collected was gathered from a foot and a half down. All
of these factors are important and should be utilized to culture a wide variety of bacteria,
especially a tester strain such as E. faecalis. As stated before, this strain has the ability
to withstand huge fluctuations in temperature, is able to thrive in both aerobic and
anaerobic environments, and able to survive no matter the nutrient level. A microbe of
this caliber may only be affected by a similar microbe.
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5. Objective 3: Isolation and Identification
5.1 Purpose:
After completing Objectives 1 and 2, the resulting colonies are unknown. The
only way to identify them is to isolate one colony which seems to be linked to the
inhibition. From here, tests can be run using selective or differential media to narrow
down the strain to a family with certain characteristics. Genome sequencing can also be
utilized to further identify the significant strains found.

5.2 Hypothesis:
After isolating and identifying the bacterial strain producing zones of inhibition, the
bacteria found in the soil will already be an identified strain. This strain could be utilized
and further tests could be done to examine exactly what is causing the zones.

5.3 Materials and Methods:
5.3.1 Isolation
After examining plates under all proposed growth conditions, Trial H was
performed on the soil bacteria cultured at 25 ℃ anaerobically on TSA using the .22 µm

pore size filter for bacterial isolation, see appendix 8. The same protocol was used from
Trials D-G to acquire new plates. To combat tester strain contamination, a primary plate
was made prior to stamping on the tester strain. This primary plate was stamped with the
filter and the orientation of the filter was mimicked on the plate with the tester strain.
Since the bacteria still needs to be filtered through the .65 µm and .45 µm pore
sized filters, these filters were also stamped. Two control plates were made, one of E.
faecalis and a blank TSA plate. All plates were incubated at 25 ℃ anaerobically for 24

hours. These plates were used to isolate pure colonies for identification. An inoculating
loop was flame sterilized using a Bunsen burner and ethanol. Colonies were chosen
(mark and shown in Figures 62-64) were used to pick from and inoculated into 15 mL
conical tubes filled with 10 mL of TSB each. These tubes were incubated anaerobically
for 24 hours at 25℃ until turbidity was observed and then used for all identification
procedures. Samples were taken and used to make glycerol stock of all isolates for
future use or if contamination was observed (see appendix 1a).

61
For convenience, all samples were grown aerobically at 37℃ on TSA. If colonies
appeared, these growth conditions are also favorable to the samples and the remainder
of the identification process could be carried out in the same manner.
5.3.2 DNA Sequencing
Agar slants were made using TSA in 50 mL conical tubes, see appendix 9a.
Sample 1A was used to inoculate an agar slant and placed in a sealed foam container
along with a processing form, see appendix 9b. The container was packaged and sent
for PCR sequencing at EMSL Analytical Inc. for a preliminary result, used as a guide for
the identification process. Species identification was performed using DNA sequencing
based on 16S ribosomal RNA gene. The results were compared against the GenBank
database at the National Center for Biotechnology Information (NCBI,
https://www.ncbi.nlm.nih.gov/). DNA sequence analysis was performed using the BLAST
search at NCBI. The lab used universal primer 357F and bacterial primer 1100R to
sequence the samples.

5.3.3 Identification Stage One
The first test utilized was Gram staining to observe cell morphology and if the
unknown isolates were Gram positive or Gram negative, see appendix 10. Using a glass
dropper, a sample of 1A was placed on a sterilized glass slide and heat sealed. The
slide was waved over a flame several times and left on a drying rack next to the flame to
dry. Once sealed, the slide was flooded with crystal violet and stain was left for 1 minute.
The slide was then rinsed with dI water. After rinsing, iodine was placed on the slide and
left for another minute. After rinsing again with dI water, the slide was rinsed with
decolorizer for 10 seconds and then rinsed again with dI water. Lastly, the slide was
flooded with safranin and left for 1 minute. After the slide was rinsed with dI water, it was
left on a drying rack. Using an EVOS FL Auto Cell Imaging System for observation,
images were captured with the EVOS FL Auto Software at 40x magnification.
After determining that all samples were Gram positive, the following dichotomous
key was used for the remainder of the identification process (Figure 60). Through Gram
staining, it is observed that samples showed bacillus morphology and spores could be
visually detected in samples 1A, 2A, and 3A. In keeping with the dichotomous key,
samples were grown on Mannitol Salt Agar (MSA). From the working stock, a sterilized
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inoculating loop was used to streak the samples onto the MSA and incubated for 24
hours at 37℃ aerobically.
Initial tests were also completed using the three samples for confirmation of
previous results from the pathway displayed in Figure 60 and results indicated by the red
box. These tests included catalase testing, oxidase testing, growth on phenyl ethyl
alcohol agar (PEA), and growth on MacConkey agar. Standard inoculating procedures
on agar and identification test protocols were used for all initial identification tests.

Figure 60: Gram Positive Dichotomous Key. After Gram staining, this key was chosen to follow for
identification. Modified from http://faculty.lacitycollege.edu/hicksdr/newkeysUnknowns.htm
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5.3.4 Identification Stage Two
Results from all initial tests from Identification Stage One were consistent with
characteristics of Bacillus Group 1 bacteria. This allowed identification to continue using
the following Bacillus Group 1 dichotomous key, Figure 61.

Figure 61: Bacillus Group 1 Dichotomous Key. All four strains from Bacillus group 1 (usually identified by
Bacillus cereus) are very similar and can only be identified by these three tests. Modified from
http://www.sfam.org.uk/download.cfm?docid=A8649AF0-52D3-4098-A5FF68A2D1A0978B

From the working stock, a 50 µL of each of the three samples was pipetted onto
three individual 50 mm plate with TSA. A lawn of the samples was created with Roll &
Grow Plating Beads from MP Biomedicals (115000550). For the penicillin susceptibility
testing, a penicillin antibiotic disc was placed in the middle of the agar plates to incubate
and measure any ZOIs. Plates were incubated for 12 hours at 37℃ aerobically.
Samples of soil bacteria working stock were streaked on TSA plates and
incubated for 6 hours at 37℃ aerobically in preparation of motility and crystal formation
testing. For motility testing, three tubes of prepared MIO (Motility Indole Ornithine)
Medium from Thermo Scientific were used to test individual colonies. The metal pick with
a colony sample was stabbed into the MIO agar and pulled out. This was done for all
three samples. MIO agar tubes were incubated as directed for 24 hours at 37℃
aerobically. Motile bacteria will tend to grow and migrate away from the initial agar stab.
To observe crystal formation, samples were stained with malachite green, as
directed in appendix 11. Microscope slides were prepared for testing in the same
manner as described for Gram staining. A Bunsen burner was used to heat seal each
sample. Each slide was flooded with malachite green and left for one minute. Each slide
was then rinsed with dI water. Safranin was used to flood each slide and left for one
minute. Each slide was rinsed again with dI water and left to dry. If samples absorb the
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malachite green stain, this indicates a positive result for crystal formation. Safranin was
used to identify non-crystal forming bacteria (30). After drying, the EVOS microscope
was used to observe and analyze the results, identifying each sample.

5.4 Results:
5.4.1 Isolation
Nine colonies were isolated from the three samples acquired in Trial H. Samples
were named Sample 1A, 1B, 1C, 2A, 2B, 2C, 3A, 3B, and 3C, shown in Figures 62-64.
These nine cultured colonies were placed in glycerol for long-term storage in -80℃ under
the label “AN Z1 .22 25 AN”. Only colony A of each sample was used for identification
since they are representative of the plate.

A

B

Figure 62: Trial H Isolated Colonies Sample 1. A. The .22 µm filter was stamped onto a blank TSA plate
(right) and TSA plate with an E. faecalis lawn (left). B. By placing the two plates over each other, colonies
can be identified that are involved in producing zones of inhibition in Sample 1 which were incubated
anaerobically at 25℃ for 24 hours.

A

B

Figure 63: Trial H Isolated Colonies Sample 2. A. The .22 µm filter was stamped onto a blank TSA plate
(right) and TSA plate with an E. faecalis lawn (left). B. By placing the two plates over each other, colonies
can be identified that are involved in producing zones of inhibition in Sample 2 which were incubated
anaerobically at 25℃ for 24 hours.
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B

A

Figure 64: Trial H Isolated Colonies Sample 3. A. The .22 µm filter was stamped onto a blank TSA plate
(right) and TSA plate with an E. faecalis lawn (left). B. By placing the two plates over each other, colonies
can be identified that are involved in producing zones of inhibition in Sample 3 which were incubated
anaerobically at 25℃ for 24 hours.

5.4.2 DNA Sequencing
An agar slant inoculated with Sample 1A was sent on July 21, 2016 to EMSL
Analytical Inc. 200 Route 130 North, Cinnaminson, NJ 08077. The lab received the
package and processed the sample along with samples from Vash Patel under order
#611601036. The results of the sequenced results were sent back on July 28, 2016.
The lab results, shown in Table 13, indicated that Sample 1A is part of Group 1 Bacillus.
Samples 2A and 3A could potentially be from the same group. Identification of all three
samples moved forward using these results as support and a framework for the process.
After receiving these results, further identification testing was done to confirm the results
as well as identify Samples 2A and 3A using differential and selective media.

Table 13: M192 DNA Sequencing Analysis for Bacterial Analysis of Sample 1A. DNA sequencing lab
results from EMSL Analytical Inc. were used as a guide to work from for the identification of Samples 1A,
2A, and 3A. The lab tested using primers 357F and 1100R and concluded that the strain from 1A were
similar to the four listed bacterial strains (Bacillus Group 1).

5.4.3 Identification Stage One
After Gram staining, results showed that all three samples were rod shaped and
tested Gram positive as seen in Figure 65. Stains were viewed through an Invitrogen
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EVOS FL Auto Cell Imaging System and images were captured using the EVOS FL Auto
Software at 40x magnification.

A.

B.

C.

Figure 65: Stage One Gram Staining. Images captured using the EVOS microscope and software at 40x.
A. Sample 1A B. Sample 2A C. Sample 3A. The staining shows all to be Gram positive bacillus strains.

Samples grown on Mannitol Salt Agar displayed no colonies and the agar
remained red. This indicated that the strains do not ferment mannitol and all originated
from Bacillus Group 1. These results prompted additional tests to confirm results, shown
on Table 14.
Table 14: Stage One Identification Testing. Results of all initial tests carried out to confirm that all
samples can be classified as Bacillus Group 1.

Sample
Number

Gram
staining

PEA

MAC

Catalase
Test

Oxidase
Test

Mannitol

1A

Positive

Growth

No growth

Positive

Negative

No growth

2A

Positive

Growth

No growth

Positive

Negative

No growth

3A

Positive

Growth

No growth

Positive

Negative

No growth

5.4.4 Identification Stage Two
When observing the agar, there is complete growth coverage over the surface of
the agar with no indication of inhibition. This shows that all samples are resistant to
penicillin, eliminating Bacillus anthracis as an option, results shown in Figure 66.
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Figure 66: Stage Two Penicillin Susceptibility Testing. Penicillin susceptibility testing for samples 1A,
2A, and 3A were completed on TSA with antibiotic penicillin discs incubated at 37℃ for 24 hours. The results
showed that all three samples were resistant to penicillin.

In the second step of Stage Two Identification, all MIO agar tubes were analyzed
and only Sample 1A showed to be non-motile, only having growth along the area
stabbed by the inoculating loop. Samples 2A and 3A tested as motile strains as
indicated by the cloudy agar indicating migrated growth, results shown in Figure 67.

A

B

C

Figure 67: Stage Two Motility Testing. Motility tests were completed using MIO agar, incubated at 37℃ for
24 hours as directed by Thermo Scientific. Sample 1A (A) shows a non-motile strain. Samples 2A (B) and
3A (C) show motile strains
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After motility testing, Sample 1A could be confidently identified as Bacillus
mycoides. To identify Samples 2A and 3A, malachite stain was used to observe crystal
formation. Safranin was used to visualize any bacteria that would not absorb malachite
green stain. Sample 1A was also stained for confirmation, results shown below. Both
Sample 1A and 2A tested negative for crystal formation which can be confirmed by the
pink coloration from the safranin, indicating lack of malachite green absorption shown in
Figure 68A and 68B. In the case of Sample A, this is consistent with Bacillus mycoides.
However, Sample 3A has fully absorbed the malachite green stain, resulting in the green
coloration shown in Figure 68C. This indicates that Sample 3A does produce cuboidal
endospores during sporulation.

A

B

C

Figure 68: Stage Two Malachite Green Staining. The sample was initially stained with malachite green
and then with safranin. Results for the staining show that Sample 1A (A) and 2A (B) are not crystal forming
bacterial strains but Sample 3A (C) stains positive for crystal formation.

Using all the data from the tests performed, Table 15 shown below confirms the
identity of the bacterial strains.
Table 15: Stage Two Identification Testing. This table shows all the results from stage two of identification
as directed by the dichotomous keys, as well as the concluded identity of the strains.

Sample
Number

Penicillin
Susceptibility

Motility

Crystal
Formation

Identification

1A
2A

Resistant
Resistant

Non-motile
Motile

Negative
Negative

Bacillus mycoides
Bacillus cereus

3A

Resistant

Motile

Positive

Bacillus thuringiensis
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5.5 Discussion:
These plates show that replication of results is possible under different growth
conditions. The tester strain was still inhibited by the bacteria found in the same soil
sample used in all previous trials. In addition, since the filter was initially stamped on a
blank TSA plate, colonies are useable to isolate and identify in Objective 3 without
contamination of the tester strain. There are clear, individual colonies which allow a
single bacterial culture to be produced in broth and used for identification. After isolating
the colonies, Samples 1A, 2A, and 3A seemed to be most representative of the bacteria
producing ZOIs. With DNA sequencing, a framework was put in place for the
identification process, pointing towards Bacillus Group 1 strains (30). Bacillus anthracis,
Bacillus cereus, and Bacillus mycoides have standard characteristics that differentiate
them, such as motility and colony morphology. However crystal formation is the only trait
that distinguishes Bacillus thuringiensis from the other three. During sporulation, Bacillus
thuringiensis produces delta-endotoxin, a cuboidal or diamond shaped crystal which can
only be visible through malachite staining (30). Malachite green is able to stain these
crystals, showing a green color when viewed on a microscope. Safranin is used to stain
the bacteria that do not absorb the malachite green so that they are visible.
These strains created the most significant ZOIs found after the completion of
Objective 2 with tester strain E. faecalis. Using this information, effective antibiotics
could potentially be created using these strains as a base. In many cases, Bacillus
Group 1 bacteria are found in insect-rich environments and only used as possible
fertilizers (30). Due to their natural environments, they are able to withstand a wide array
of conditions, with optimal growing temperatures between 5℃ - 50℃ at various levels of
humidity (30). They seem to be resilient, making them a good possible defense against
ESKAPE pathogens. Further tests should be done on bacterial secretions and their
continued effects on tester strains, especially E. faecalis. It would be valuable to observe
the effect of these secretions not only on the tester strains, but also on the human host
and if these secretions are harmful. The exact mechanism which allows Bacillus Group 1
bacteria to form these inhibitory zones should also be examined as well as the
probability of forming a resistant strain to this group.
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Appendix 1a Culturing E. faecalis and Freezing in Glycerol
Rationale: Strain has been acquired through a frozen pellet. E. faecalis needs to be
cultured and inoculated into glycerol for frozen storage.
Materials:
Enterococcus faecalis (ATCC 29212)
Tryptic Soy Broth (TSB) (Carolina Prod #)
Tryptic Soy Agar (TSA) (Carolina Prod #)
Inoculating loop
Bunsen burner
15 mL culture tubes
2 mL Cryo Tubes (screw cap)

Procedure to culture E. faecalis:
1. Prepare 5 mL of TSB in a 15 mL conical tube.
2. Open vial according to enclosed instructions (attached).
3. Using a pipette, rehydrate the entire pellet with approximately 1 mL of TSB inside
the pellet container.
4. Pipette the solution to mix and transfer the contents to a 15 mL culture tube filled
with 5 mL of TSB.
5. Using the sample in this tube, sterilize an inoculating loop and take a sample
6. Streak a TSA plate with the sample. Streaked plate should show individual
colonies after incubation.
7. Incubate both broth and agar samples at 37℃ for 24 hours in an incubator.
8. Remove tube and plate from incubator and store at 4℃ until needed.
Procedure to store E. faecalis:
1. Using the TSA streaked plate, identify 3 individual colonies on the agar.
2. Using a sterilized loop, take a sample of each of these colonies and inoculate
into three individual conical tubes with 15 mL of TSB, one for each sample.
3. Incubate these tubes at 37℃ until some turbidity becomes visible. Be sure to
vortex the sample before adding to glycerol.
4. Take three screw cap cryo tubes and fill each with 500 μL of 50% glycerol.
5. Take the inoculated conical tubes and add 500 μL of each sample to the
corresponding cryo tube. Keep the remaining broth as a working stock. Replace
the working stock every 2-3 weeks.
6. Freeze the glycerol tubes at -80° C.
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Appendix 1b E. faecalis ATCC 29212 Product Sheet
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Appendix 2a Growth Curve Using Beckman Coulter DU 730 Life
Science UV/Vis Spectrophotometer
Rationale: A growth curve for the tester strain needs to be established so that
introduction of other bacteria can be done correctly and in the appropriate time frame.
This method was used to decrease incubation time.
Materials:
Tryptic Soy Broth (TSB)
E. faecalis working stock
15 mL conical tubes (for each temperature setting)
1 mL pipettor
1 µL pipettor
1 mL cuvettes
dI water
Beckman Coulter DU 730 Life Science UV/Vis Spectrophotometer
Procedure:
1. Divide the six conical tubes into two sets of three. Indicate set 1 (red) and set 2
(blue).
2. Fill each conical tube with 10 mL of TSB.
3. Inoculate each TSB filled conical tube with 1 µL of the tester strain.
4. Place set 1 in the incubator and store set 2 at 4℃ for 12 hours.
5. After 12 hours, place set 2 in the incubator and take OD reading for set 1.
Schedule depicted in the attached figure.
6. To take an OD reading, prepare a clean and sterile cuvette. Place dI water in a
cuvette to blank the spectrophotometer. Place 1 mL of the tester strain in a
separate cuvette for readings.
7. To set up the spectrophotometer, turn on the machine. Set the wavelength
readings to 450 nm - 750 nm to capture the desired range.
8. Place cuvette into the reader and proceed to measure the OD readings.
9. Save data on USB.
10. Repeat this process every 3 hours.
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Appendix 2b Growth Curve Using Synergy HT Microplate Reader
Rationale: A growth curve for the tester strain needs to be established so that
introduction of other bacteria can be done correctly and in the appropriate time frame.
This method was used to decrease incubation time and minimize contamination.
Materials:
E. faecalis working stock
Tryptic Soy Broth (TSB)
6-well plate
1 mL pipettor
.01 µL pipettor
dI water
Synergy HT microplate reader
Gen5, version 2.00.18, BioTek (Winooski, VT, USA) software

Procedure:
1. In the 6-well plate, place 1 mL of TSB
in wells A1, A2, B1, B2, and B3.
2. Place .02 µL of the tester strain in A2,
B2, and B3.
3. Place a plastic seal over the top of the
plate to keep from contaminating the
reader.
NOTE: Make sure that the computer in use for the reads does not turn off.
4. Place the plate into the tray of the microplate reader, with the A1 well in the
appropriate spot.
5. Open up the Gen5 software and create a new reader file.
6. Open the ‘Procedure’ tab in the left menu.
7. Under ‘Plate Type’, set the reader to a 6-well plate with the drop down menu at
the top of the window.
8. Using the left menu, click on ‘Procedure’ to setup the parameters of the read
(example of the windows below).
a. Click on ‘Set Temperature’ under ‘Actions’. Set desired temperature.
b. Under ‘Kinetic’, click on ‘Start Kinetic’ and set up how long the read will
last, and at what interval each reading will occur.

78
c. Under ‘Actions’ click on ‘Read’ and choose the ‘Wavelength’ option. For
this protocol, input 600 and 650. Drag this option between the start and
end of the read.
d. Under ‘Actions’, click on ‘Shake’ and set the reader to shake orbitally and
continuously. Drag this option between the start and end of the read.
e. Click ‘Ok’ when tasks are complete.

Note: The ‘Descriptions’ menu should show the following:
→ Set temperature: 37℃
→ Start read (24:00:00) Interval (01:00:00)
→ Read (600, 650)
→ Shake (orbital, continuous)
→ End read
9. To label the plates, click on the ‘Plate Layout’ tab on the left main menu.
a. A gridded window will open with squares representing each of the wells in
the plate.
b. In the left menu of the ‘Plate Layout’ Window, three categories are
present (Assay Control, Sample, and Blank). Label the wells under the
appropriate categories.
c. Click ‘Ok’ when task is finished.
10. Once the reader is set up, start the read by clicking on the ‘Start Read’ icon
(indicated by a green play button) located in the top main task bar.
11. Once the reader has reached the desired temperature, a window will open asking
if the user wants to proceed. Click ‘Ok’ to start read.
12. When the protocol has been completed, export the acquired information onto an
excel spreadsheet.
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Appendix 3 Gathering Soil Samples
Rationale: For this step, soil samples are a prime source of antibiotic secreting microbes.
A diverse location should be chosen prior to this step, allowing for the most abundant
resource. Locations that have not been extensively studied are best.
Materials:
Soil probe
Sterile sample bags
Sterile plastic trowel
Procedure:
1. Identify a suitable location to collect soil samples.
2. Drive the soil probe into the ground, approximately a foot in depth and slowly
empty the contents into a sterile collection bag. Each bag should contain
approximately 50 grams of soil.
3. If needed, use a plastic trowel to loosen the soil and scoop into the bag from the
soil probe. Discard trowel after use.
4. Record GPS coordinates and weather/environment conditions.
5. Repeat steps for each sample section. Sample section should be representative
of the entire sample location, showing a range.
Sample Conditions Table
GPS Coordinates
Sample 1

Sample 2

Sample 3

Sample 4

Temperature

Humidity
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Appendix 4 Drying Soil Samples
Rationale: Drying the samples will decrease the amount of mold and fungi that will
develop in the sample which would cloud the results of any test performed on the soil.
This will also allow the samples to be more workable since the soil will not be clumped
up from moisture.

Materials:
Sterile soil bags
Paper towels
Sterile plastic trowel
Sterile fume hood with blower

Procedure:
1. Place individual samples on layers of clean paper towels. Evenly spread the soil
samples to a thin layer over the paper towels for optimal drying.
2. Place samples inside a fume hood equipped with a blower. Turn blower on.
3. Depending on the sample size, allow the soil sample to sit under the hood for 2448 hours for drying.
4. After the allotted time, check the soil for visual cues that the soil is dry. Remove
the
5. Remove samples from the hood and rebag the soil. Samples should be stored in
a dry area at 4°C.
6. If condensation were to form inside the bag after 24 hours, the soil has not
adequately dried and the process needs to be repeated until no condensation
occurs.
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Appendix 5 Plate Preparation
Rationale: Bacteria filtered through the soil will be grown on agar plates in the presence
of E. faecalis to observe any antibiotic activity.
Materials:
Tester strain (E. faecalis, previously cultured)
Tryptic Soy Agar (TSA)
Bioworld R2A Low Nutrient Agar mix
Roll & Grow Plating Beads MP Biomedicals
50 mm plates
Procedure:
1. Prepare one liter of TSA and Low-nutrient agar using the Carolina Supply mix
and the Bioworld mix as directed. Autoclave the mixture after both mixes are fully
dispersed in the dI water.
2. Once autoclaved, pour approximately 5 mL of agar per 50 mm plate. These
plates will be used to create master plates from the filter papers.
3. Divide the plates into two groups, one group of 2 TSA plates and one group of 2
Low-nutrient agar plates.
4. Take the TSA and Low-nutrient agar plates and prepare for culturing.
a. For culturing plate preparation, take each plate and inoculate with a 50 μL
sample of Enterococcus faecalis. Using 3-5 sterile beads, roll the sample
onto the agar to create a lawn. Repeat until all plates have been prepared
for culturing.
5. One set of 4 plates accounts for a pore size at one temperature setting, to be
incubated aerobically and anaerobically. Repeat for each temperature setting
and each pore size.
6. Use the following chart for appropriate incubation time to reach the log phase
before pressing filters into agar.
Temperature

Incubation Time
(shaking)

Incubation Time (no
shaking)

18 ℃

10 hours

12 hours

25 ℃

8 hours

8 hours

37 ℃

4 hours

4 hours

43 ℃

3 hours

3 hours
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Appendix 6 Filtering and Extracting Bacteria from Soil
Rationale: Filtration will process the microbes living in the soil into differing sizes. This
will make culturing easier by capturing the microbes into various filter papers according
to size. Categorizing by size will also help with identification.
Materials:
Sartorius Filter Discs Grade 389 100 mm 2 µm
Sartorius Cellulose Nitrate Filter Papers (sizes .22 µm, .45 µm, and .65 µm)
Fisherbrand Porcelain Buchner Funnel with Perforated Plates
Erlenmeyer vacuum flask
Vacuum, Vacuubrand vacuum pump unit PC 101 NT series
Rubber tubing
2 Rubber Stoppers
18 Sterile bags
120 mL of dI water
15 mL conical tubes
Sterile fume hood

Procedure:
1. Assemble filtration device (as shown in the diagram). A vacuum is connected to
the Erlenmeyer flask through a rubber tube and rubber stopper. The Buchner
funnel is attached to the Erlenmeyer flask through a rubber stopper. Filter papers
should be placed inside the Buchner funnel, one at a time to collect bacteria.
2. Take 12 grams of soil from the sample bag and dissolve in 120 mL of dI water in
a sterile beaker. Use magnetic stir bars and place inside the beaker to thoroughly
mix and homogenize the solution. Allow the solution to mix for approximately 15
minutes before filtering.
3. Filter entire contents of the soil solution through the Sartorius Filter Discs Grade
389 100 mm 2 µm. After filtering, approximately 75 mL of filtrate is collected.
4. Take 15 mL of the filtrate and store in a 15 mL conical tube at 4℃ for future use.
5. Divide the remaining filtrate into 6 equal parts, 10 mL for each aliquot. Each
aliquot will be filtered 3 times through each of the three Sartorius Cellulose
Nitrate Filters (sizes .22 µm, .45 µm, and .65 µm). Remove each filter and
replace with the following pore size for adequate filtration.
6. Take each filter and place in sterile seal until ready for stamping. See Protocol 6
for culturing.
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Appendix 7 Culturing Bacteria from Soil
Rationale: Bacteria will be cultured in the presence of E. faecalis to observe any
antibiotic secretions which will arise.
Materials:
Previously acquired filter papers
Previously prepared agar plates with E. faecalis lawn
Mitsubishi™ AnaeroPack 2.5L Rectangular Jars
Mitsubishi™ AnaeroPack-Anaero Anaerobic Gas Generator
Mitsubishi™ AnaeroPack-Anaero Anaerobic Indicator
Incubator
Glass hockey stick
Tweezers

Procedure:
1.
2.
3.
4.

Incubate E. faecalis plates for approximately one hour.
As plates are incubating, add 12 grams of soil sample to 120 mL of dI water.
Filter soil appropriately as previously discussed in Appendix 6.
Take each filter and invert onto an agar intended for master plate production.
Each filter will be used for two agar plates (aerobic and anaerobic). Lightly press
the filter onto the agar to transfer bacterial colonies with glass hockey stick. See
Figure 1 and 2 for details.
5. Place one of each TSA and Low-nutrient agar plate in an incubator at 18°C. Do
this for 25°C and 37°C. This process should be done for both anaerobic and
aerobic conditions, as shown in the diagram illustrated below.
a. For aerobic: place in a standard incubator and use the growth
curve graphs for an estimation of appropriate time intervals for incubation.
b. For anaerobic: place plates in Mitsubishi™ AnaeroPack 2.5L
Rectangular Jar with Mitsubishi™ AnaeroPack-Anaero Anaerobic Gas Generator
and Indicator. Close lid and seal.
6. Plates should be monitored every 2 hours for a 12 hour period.
7. Once single colonies are observed, record time period for replication and remove
the agar plates. Store at 4°C.
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For aerobic

For anaerobic

Note: There should be a total of 36 different plates when accounting for all growth
conditions (as shown).

85

Appendix 8 Soil Bacteria Colony Isolation
Rationale: After culturing under all the previously discussed conditions, plates with
distinct zones of inhibition are analyzed and colonies showing signs of secreting
antibiotic-like substances should be explored. Culturing them and isolating colonies
needs to be done before identification.
Materials:
Previously cultured agar plates
Previously prepared agar plates
Bunsen burner
Inoculating loop
Conical tubes
Tryptic Soy Broth (TSB)
Incubator
Sterile toothpicks
200 µL pipettor
Tester strain

Procedure Part I:
1. On the bottom of the previously prepared cultured agar plates, mark significant
colonies to pick samples from. Samples should be from colonies that show a
relationship to the zones of inhibition.
2. Prepare media for inoculation. Add 20 mL of TSB to a 50 mL conical tube, one
for each sample. Be sure to label the conical tubes with the corresponding plate
and colony sample.
3. Prepare the inoculating loop by running it over the flame from the Bunsen burner.
Loop should turn red hot.
4. Using the sterile inoculating loop, pick a small sample of the chosen colony.
5. Inoculate the TSB, making sure the the loop is fully immersed into the TSB.
6. Place into incubator according to the growth conditions present on the Figure --.
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Note: Charts compiled using data from Objective 2. Data shows observed levels of
zones of inhibition using all growth conditions. Pink boxes show inhibition in all three
trials. Green boxes show inhibition in two trials. White shows inhibition in only one trial or
none.
Procedure Part II:
1. Take an inoculating loop and sterilize with a flame (described in Procedure Part I,
Step 3).
2. Using the inoculating loop, streak a blank TSA plate and incubate according to
the appropriate growth conditions.
3. Once colonies become apparent, store the plates at 4℃ for future use.
Procedure Part III:
1. Prepare solutions for glycerol stock using 50% glycerol and 50% TSB. In a cryo
tube, add 250 µL dI water and 250 µL glycerol using a pipette. Make a set of two
for each sample.
2. From the sample made in Procedure Part I, add 500 µL of the sample to each
cryo tube. Remember to pipette up and down to mix.
3. Seal the cryo tubes and store at -80 ℃ for future use.
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Appendix 9a Preparing Samples for DNA Sequencing
Rationale: To identify the bacterial samples, DNA sequencing can be utilized to confirm
lab results found from differential and selective media.
Materials:
Previously cultured strains in broth
Pourable Tryptic Soy Agar (TSA)
Pipette
50 mL conical tubes
Slant rack or test tube rack that can be elevated
Inoculating Loop
Bunsen burner
Isopropyl ethanol
Vortex Genie 2 Lab Mixer

Procedure:
1. After preparing the TSA as directed, use the pipette to pour 20 mL of the agar
into the 50 mL conical tubes. Pour as many as needed, one for each sample.
2. Place all conical tubes into a slant rack or test tube rack. If using a test tube rack,
elevate one side of the rack so that the test tubes are sitting at a 30° angle. Let
the agar cool.
3. Once solidified, take inoculating loop and sterilize. Use the Vortex Genie to mix
all cultures.
4. Using the inoculating loop, take a sample of the cultured broth and streak the
sample onto the agar slants. Do this for all samples.
5. Place the tubes in a sealed container and prepare for packaging.
NOTE: EMSL Analytic Inc. required a processing form to accompany the samples.
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Appendix 9b EMSL Analytical Inc. PCR Sequencing Processing
Form
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Appendix 10 Gram Staining
Rationale: To start the identification process, bacterial samples need to be categorized
into Gram positive or Gram negative. Then follow up testing can be done to further
narrow down and identify.
Materials:
Previously cultured agar plates
3 Microscope slides
Dropper and bulb
Crystal Violet
Iodine
Safranin
dI Water
Sterile Toothpicks
Acetone
Bunsen burner
EVOS microscope and Image capturing software

Procedure:
1. On each microscope slide, add dI water to the surface, about 3-5 drops. Do this
three times for three Gram stains per bacterial sample.
2. From the previously cultured agar plates, isolate a colony and using a sterile
toothpick, take a sample. Add this sample to the dI water. Do this for both
samples on each slide.
3. Using the Bunsen burner, wave the slide gently over the flame to heat seal the
sample.
4. Once sample is heat seal, flood the slide using a dropper with crystal violet.
Leave on for 1 minute. Rinse with dI water.
5. Flood slide with iodine and leave on for 1 minute. Rinse with dI water and raise
with acetone right after. Make sure to only rinse with acetone for about 5-10
seconds. Rinse with dI water again after the acetone.
6. Flood slide with safranin and leave on for 1 minute. Rinse with dI water.
7. Let dry and use EVOS microscope to observe and capture images.
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Appendix 11 Malachite Green Staining
Rationale: In the last stage of identifying Group 1 Bacillus, staining the bacterial samples
with malachite green will reveal any strains that produce a cuboidal crystal deltaendotoxin.
Materials
Microscope slides
Sterile toothpicks
dI water
Previously cultured bacterial samples on agar
Bunsen burner
Malachite green stain
Safranin stain

Procedure:
1. Prepare work station and attach and light Bunsen burner.
2. On each microscope slide, add dI water to the surface, about 3-5 drops. Do this
three times for three malachite stains per bacterial sample.
3. From the previously cultured agar plates, isolate a colony and using a sterile
toothpick, take a sample. Add this sample to the dI water. Do this for both
samples on each slide.
4. Using the Bunsen burner, wave the slide gently over the flame to heat seal the
sample.
5. Once sealed and dry, add 3-5 drops of malachite stain onto the samples. Let sit
for 1 minute. Rinse with dI water.
6. Add 3-5 of safranin to each sealed sample. Let sit for 1 minute. Rinse with dI
water.
7. After slides have dried, examine staining with a microscope
NOTE: Samples that test positive for cuboidal crystal formation will stain green. Samples
that test negative will stain pink.

